• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞衰老:糖尿病与微血管病变之间的桥梁。

Cellular Senescence: A Bridge Between Diabetes and Microangiopathy.

机构信息

The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China.

Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou 730000, China.

出版信息

Biomolecules. 2024 Oct 25;14(11):1361. doi: 10.3390/biom14111361.

DOI:10.3390/biom14111361
PMID:39595537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11591988/
Abstract

Cellular senescence is a state of permanent cell cycle arrest and plays an important role in many vascular lesions. This study found that the cells of diabetic patients have more characteristics of senescence, which may cause microvascular complications. Cell senescence, as one of the common fates of cells, links microangiopathy and diabetes. Cell senescence in a high-glucose environment can partially elucidate the mechanism of diabetic microangiopathy, and various types of cellular senescence induced by it can promote the progression of diabetic microangiopathy. Still, the molecular mechanism of microangiopathy-related cellular senescence has not yet been clearly studied. Building on recent research evidence, we herein summarize the fundamental mechanisms underlying the development of cellular senescence in various microangiopathies associated with diabetes. We gradually explain how cellular senescence serves as a key driver of diabetic microangiopathy. At the same time, the treatment of basic senescence mechanisms such as cellular senescence may have a great impact on the pathogenesis of the disease, may be more effective in preventing the development of diabetic microangiopathy, and may provide new ideas for the clinical treatment and prognosis of diabetic microangiopathy.

摘要

细胞衰老(Cellular senescence)是一种细胞周期永久停滞的状态,在许多血管病变中发挥着重要作用。本研究发现,糖尿病患者的细胞具有更多衰老特征,这可能导致微血管并发症。细胞衰老作为细胞的常见命运之一,将微血管病变与糖尿病联系起来。高糖环境中的细胞衰老部分阐明了糖尿病性微血管病变的机制,而其诱导的各种类型的细胞衰老则促进了糖尿病性微血管病变的进展。然而,与糖尿病相关的微血管病变相关细胞衰老的分子机制尚未得到明确研究。基于最近的研究证据,我们在此总结了与糖尿病相关的各种微血管病变中细胞衰老发展的基本机制。我们逐渐解释了细胞衰老如何作为糖尿病性微血管病变的关键驱动因素。同时,对细胞衰老等基本衰老机制的治疗可能对疾病的发病机制有重大影响,可能更有效地预防糖尿病性微血管病变的发展,并为糖尿病性微血管病变的临床治疗和预后提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/01d0c044eb82/biomolecules-14-01361-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/616af6813b3e/biomolecules-14-01361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/3dcfad59555e/biomolecules-14-01361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/10412cb1ecde/biomolecules-14-01361-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/1815bb16de55/biomolecules-14-01361-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/01d0c044eb82/biomolecules-14-01361-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/616af6813b3e/biomolecules-14-01361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/3dcfad59555e/biomolecules-14-01361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/10412cb1ecde/biomolecules-14-01361-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/1815bb16de55/biomolecules-14-01361-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd32/11591988/01d0c044eb82/biomolecules-14-01361-g005.jpg

相似文献

1
Cellular Senescence: A Bridge Between Diabetes and Microangiopathy.细胞衰老:糖尿病与微血管病变之间的桥梁。
Biomolecules. 2024 Oct 25;14(11):1361. doi: 10.3390/biom14111361.
2
Role of Asymmetrical Dimethylarginine in Diabetic Microvascular Complications.不对称二甲基精氨酸在糖尿病微血管并发症中的作用。
J Cardiovasc Pharmacol. 2016 Oct;68(4):322-326. doi: 10.1097/FJC.0000000000000414.
3
Roles of Sirt1 and its modulators in diabetic microangiopathy: A review.Sirt1 及其调节剂在糖尿病微血管病变中的作用:综述。
Int J Biol Macromol. 2024 Apr;264(Pt 2):130761. doi: 10.1016/j.ijbiomac.2024.130761. Epub 2024 Mar 11.
4
Endothelial Extracellular Vesicles Produced by Senescent Cells: Pathophysiological Role in the Cardiovascular Disease Associated with all Types of Diabetes Mellitus.衰老细胞来源的内皮细胞外囊泡:与所有类型糖尿病相关心血管疾病中的病理生理作用。
Curr Vasc Pharmacol. 2019;17(5):447-454. doi: 10.2174/1570161116666180820115726.
5
Nox4 as a novel therapeutic target for diabetic vascular complications.Nox4 作为糖尿病血管并发症的一个新的治疗靶点。
Redox Biol. 2023 Aug;64:102781. doi: 10.1016/j.redox.2023.102781. Epub 2023 Jun 9.
6
Manifestations of cutaneous diabetic microangiopathy.皮肤糖尿病微血管病变的表现。
Am J Clin Dermatol. 2005;6(4):225-37. doi: 10.2165/00128071-200506040-00003.
7
Neuregulin-1 attenuates stress-induced vascular senescence.神经调节蛋白-1 可减轻应激诱导的血管衰老。
Cardiovasc Res. 2018 Jun 1;114(7):1041-1051. doi: 10.1093/cvr/cvy059.
8
Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.精氨酸脱羧酶抑制剂在 2 型糖尿病微血管并发症发病机制中的作用。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1183586. doi: 10.3389/fendo.2023.1183586. eCollection 2023.
9
The problems of tissue oxygenation in diabetes mellitus. III. The "three-in-one concept" for the development of diabetic microangiopathy and a rational approach to its prophylaxis.糖尿病中的组织氧合问题。III. 糖尿病微血管病变发展的“三位一体概念”及其预防的合理方法。
Acta Med Scand Suppl. 1975;578:69-83.
10
Diabetic microangiopathy, genetics, environment, and treatment.糖尿病微血管病变、遗传学、环境与治疗
Am J Med. 1988 Nov 28;85(5A):119-30. doi: 10.1016/0002-9343(88)90404-4.

引用本文的文献

1
Extracellular vesicle-derived lncRNA VIM-AS1 promotes diabetic wound healing by promoting glycolysis and alleviating cellular senescence.细胞外囊泡来源的长链非编码RNA VIM-AS1通过促进糖酵解和减轻细胞衰老来促进糖尿病伤口愈合。
Stem Cell Res Ther. 2025 Jul 1;16(1):341. doi: 10.1186/s13287-025-04451-x.
2
Multifunctional hydrogel targeting senescence to accelerate diabetic wound healing through promoting angiogenesis.通过促进血管生成靶向衰老以加速糖尿病伤口愈合的多功能水凝胶。
J Nanobiotechnology. 2025 Mar 6;23(1):177. doi: 10.1186/s12951-025-03274-5.
3
Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.
用于治疗糖尿病视网膜病变(DR)的天然疗法:糖尿病并发症。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 15. doi: 10.1007/s00210-025-03866-w.